Robot-assisted rehabilitation for upper limb recovery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility and cost-effectiveness of using the ReHandyBot, a robot-assisted rehabilitation device, for patients with upper limb sensorimotor deficits. The device allows patients to engage in therapy with minimal to no supervision, potentially increasing the therapy dose while reducing the need for additional resources. The study aims to assess how well the ReHandyBot can be integrated into rehabilitation clinics and perform a cost-benefit analysis comparing different levels of supervision during therapy. Additionally, it will investigate the intensity of use and the effectiveness of the therapy in improving patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Informed Consent signed by the subject.
* Female and male patients between 18 and 90 years old
* Presence of an upper limb deficit derived from any disease or event that, according to the responsible clinicians, could be improved by therapy with ReHandyBot.

Exclusion Criteria:

* Pathologies that may interfere with the training with ReHandyBot.

Where it's running

• Clinica Hildebrand Centro di riabilitazione Brissago
  Brissago, Switzerland Recruiting
• Clinica Hildebrand Centro Ambulatoriale Lugano
  Lugano, Switzerland Recruiting

Study contacts

• Study coordinator: Giada Devittori, Dr.
• Email: giada.devittori@hest.ethz.ch
• Phone: 0041445107234

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized home exergame program to improve balance and thinking in frail older adults

  This program will test whether a personalized, home-based exergame training helps frail adults improve balance and their thinking-and-movement skills.

  Recruiting Swiss Federal Institute of Technology · Zurich · NCT07074639

• Investigating how oral iron doses affect serum ferritin levels in iron-deficient women

  This study tests how different doses of iron supplements affect iron levels in women aged 18 to 45 who have low iron but are not anemic.

  Recruiting Swiss Federal Institute of Technology · Zurich, Canton of Zurich · NCT06851130

• Examining exercise effects on heart activity in ARVC patients

  This study tests how different types of exercise affect heart activity in people with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) to help create safer exercise guidelines for them.

  Recruiting Swiss Federal Institute of Technology · Zurich, Canton of Zurich · NCT06040242

• Investigating brain activity related to walking in Parkinson's patients

  This study looks at how the brains of people with Parkinson's disease work while they walk to see if it can help create better treatments for their movement problems.

  Recruiting Swiss Federal Institute of Technology · Vitznau, Canton of Lucerne · NCT05820074

• Investigating the effects of iron supplementation on glucose metabolism during pregnancy

  This study is testing if taking iron supplements can help pregnant women with gestational diabetes and low iron levels manage their blood sugar better.

  Recruiting Swiss Federal Institute of Technology · Zurich · NCT04008147

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.